Observational study assessing changes in timing of readmissions around postdischarge day 30 associated with the introduction of the Hospital Readmissions Reduction Program
- 21 July 2020
- journal article
- research article
- Published by BMJ in BMJ Quality & Safety
- Vol. 30 (6), 493-499
- https://doi.org/10.1136/bmjqs-2019-010780
Abstract
Background The Hospital Readmissions Reduction Program (HRRP) initially penalised hospitals for excess readmission within 30 days of discharge for acute myocardial infarction (AMI), congestive heart failure (CHF) or pneumonia (PNA) and was expanded in subsequent years to include readmissions for chronic obstructive pulmonary disease, elective total hip arthroplasty, total knee arthroplasty and coronary artery bypass graft surgery. We assessed whether HRRP was associated with delays in readmissions from immediately before the 30-day penalty threshold to just after it. Methods We included Medicare fee-for-service beneficiaries discharged between 1 January 2007 and 31 October 2015. Readmissions were assessed until December 31, 2015. The study period was divided into three phases: January 2007 to March 2009 (pre-HRRP), April 2009 to September 2012 (implementation) and October 2012 to December 2015 (penalty). We estimated additional readmissions between postdischarge days 31–35 compared with days 26–30 using a negative binomial difference-in-differences model, comparing target HRRP versus non-HRRP conditions at the same hospital in the same month in the pre-HRRP and penalty phases. Results HRRP was not associated with a significant difference in AMI readmissions between postdischarge days 31–35 versus postdischarge days 26–30 for each hospital in the penalty phase, as compared with non-HRRP conditions and the pre-HRRP phase (p=0.19). There were statistically significant increases in readmissions CHF (0.040%, 95% CI 0.024% to 0.056%, pConclusion We did not identify consistently significant associations between HRRP and delayed readmissions, and importantly, any findings suggesting delayed readmissions were extremely small and unlikely to be clinically relevant.Keywords
This publication has 22 references indexed in Scilit:
- Decreases In Readmissions Credited To Medicare’s Program To Reduce Hospital Readmissions Have Been OverstatedHealth Affairs, 2019
- Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and PneumoniaJAMA, 2018
- Association of the Hospital Readmissions Reduction Program With Mortality During and After Hospitalization for Acute Myocardial Infarction, Heart Failure, and PneumoniaJAMA Network Open, 2018
- The Hospital Readmissions Reduction Program—learning from failure of a healthcare policyEuropean Journal of Heart Failure, 2018
- Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart FailureJAMA Cardiology, 2018
- Elements of Program Design in Medicare’s Value-based and Alternative Payment Models: a Narrative ReviewJournal of General Internal Medicine, 2017
- Association Between Hospital Penalty Status Under the Hospital Readmission Reduction Program and Readmission Rates for Target and Nontarget ConditionsJAMA, 2016
- Readmission Rates After Passage of the Hospital Readmissions Reduction ProgramAnnals of Internal Medicine, 2016
- Readmissions, Observation, and the Hospital Readmissions Reduction ProgramThe New England Journal of Medicine, 2016
- Medicare's Readmissions-Reduction Program — A Positive AlternativeThe New England Journal of Medicine, 2012